Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)

被引:142
|
作者
Bouma, G
Xia, B
Crusius, JBA
Bioque, G
Koutroubakis, I
VonBlomberg, BME
Meuwissen, SGM
Pena, AS
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT GASTROENTEROL,1081 HV AMSTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP,DEPT PATHOL,1081 HV AMSTERDAM,NETHERLANDS
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1996年 / 103卷 / 03期
关键词
inflammatory bowel disease; Crohn's disease; ulcerative colitis; HLA association; tumour necrosis factor-alpha; lymphotoxin alpha; gene polymorphism; haplotype;
D O I
10.1111/j.1365-2249.1996.tb08292.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In 153 patients with IBD, 64 with Crohn's disease (CD), and 89 with ulcerative colitis (UC), as well as in 54 healthy controls (HC), the frequencies of four known di-allelic polymorphisms in the genes for TNF-alpha and lymphotoxin alpha (LT alpha) were investigated. In the Dutch population, the alleles of these four polymorphisms are present in only five combinations, called TNF haplotypes: TNF-C, -E, -H, -I, -P. Furthermore, the relation with the presence of perinuclear anti-neutrophil cytoplasmic autoantibodies (P-ANCA) was studied. A small, but statistically significant, association between the polymorphism at position -308 in the promoter region of the TNF-alpha gene and UC was found. The frequency of the uncommon TNF-alpha-308 allele 2 was found to be decreased in patients with UC compared with HC (allele frequency of allele 2 in UC patients 0.15 versus 0.25 in HC, P = 0.044). No significant differences in distribution of the TNF haplotypes were found between IBD patients and HC, although there was a tendency towards a higher frequency of the TNF-C haplotype in UC patients compared with controls (haplotype frequency 22% versus 13%; P = 0.19). No statistically significant differences in distribution of the TNF haplotypes were observed between P-ANCA-positive and P-ANCA-negative UC patients. The strength of the associations indicates that TNF genes are not markers for the predisposition to suffer from IBD. They may, however, be markers of subsets of patients with UC and CD.
引用
收藏
页码:391 / 396
页数:6
相关论文
共 50 条
  • [1] Activity of tumour necrosis factor (TNF)-α converting enzyme (TACE) in colonic mucosa from patients with inflammatory bowel disease (IBD).
    Foegh, P
    Pedersen, G
    Ellervik, C
    Saermark, T
    Brynskov, J
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A109 - A109
  • [2] Tumour necrosis factor and inflammatory bowel disease
    Densem, CG
    [J]. BRITISH JOURNAL OF SURGERY, 1998, 85 (01) : 138 - 138
  • [3] Tumour necrosis factor and inflammatory bowel disease
    Armstrong, AM
    Gardiner, KR
    Kirk, SJ
    Halliday, MI
    Rowlands, BJ
    [J]. BRITISH JOURNAL OF SURGERY, 1997, 84 (08) : 1051 - 1058
  • [4] Genetic polymorphisms of tumour necrosis factor alpha (TNF-α) promoter gene and response to TNF-α inhibitors in Spanish patients with inflammatory bowel disease
    Lopez-Hernandez, R.
    Valdes, M.
    Campillo, J. A.
    Martinez-Garcia, P.
    Salama, H.
    Salgado, G.
    Boix, F.
    Moya-Quiles, M. R.
    Minguela, A.
    Sanchez-Torres, A.
    Miras, M.
    Garcia, A.
    Carballo, F.
    Alvarez-Lopez, M. R.
    Muro, M.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2014, 41 (01) : 63 - 68
  • [5] PERSISTENCE AND ADHERENCE OF ANTITUMOUR NECROSIS FACTOR (TNF) BIOLOGICS FOR INFLAMMATORY BOWEL DISEASE (IBD) IN AUSTRALIA
    Wang, Li-Chin
    Leong, Rupert
    [J]. GUT, 2018, 67 : A298 - A298
  • [6] Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
    Bouma, G
    Crusius, JBA
    Pool, MO
    Kolkman, JJ
    VonBlomberg, BME
    Kostense, PJ
    Giphart, MJ
    Schreuder, GMT
    Meuwissen, SGM
    Pena, AS
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (04) : 456 - 463
  • [7] Tumour necrosis factor (TNF) antagonist therapy for paediatric inflammatory bowel disease: A systematic review
    Martin-Garcia, Paula
    Alonso-Arroyo, Adolfo
    Catala-Lopez, Ferran
    [J]. MEDICINA CLINICA, 2023, 160 (11): : 501 - 516
  • [8] Tumour necrosis factor α promoter polymorphisms influence disease phenotype and severity in childhood inflammatory bowel disease
    Van Limbergen, J
    Russell, RK
    Nimmo, ER
    Drummond, HE
    Anderson, N
    Wilson, DC
    Gillett, PM
    McGrogan, P
    Hassan, K
    Weaver, LT
    Bisset, WM
    Mahdi, G
    Satsangi, J
    [J]. GUT, 2006, 55 : A10 - A10
  • [9] Cutaneous Events During Anti-Tumour Necrosis Factor (Anti-TNF) Treatment at a London Inflammatory Bowel Disease (IBD) Centre
    Lim, Cheryl
    Shepherd, Thomas C.
    Cronin, Elaine A.
    Greveson, Kay
    Hamilton, Mark I.
    Murray, Charles
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S234 - S234
  • [10] Cutaneous events during anti-tumour necrosis factor (anti-TNF) treatment at a London Inflammatory Bowel Disease (IBD) centre
    Lim, C.
    Shepherd, T.
    Cronin, E.
    Greveson, K.
    Hamilton, M.
    Murray, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S308 - S309